Transradial Closure Devices Market Share

  • Report ID: 4346
  • Published Date: Nov 21, 2025
  • Report Format: PDF, PPT

Transradial Closure Devices Market - Regional Analysis

North American Market Insights

 North America industry is likely to account for largest revenue share of 37% by 2035, driven by high prevalence of heart disease in the region along with the increasing geriatric population, and accessibility of advanced healthcare facilities.According to the Centers for Disease Control and Prevention, cardiovascular disease claims one life in the United States every 34 seconds. Moreover, in 2020, approximately 697,000 people in the United States died from heart disease, accounting for 1 out of every 5 deaths. Also, the rising cases of chronic diseases, along with the increased number of patients diagnosed with cardiovascular diseases are anticipated to increase the utilization rate of transradial closure devices for performing surgeries such as coronary artery bypass grafts during the analysis period. Further, the presence of a strong healthcare network in the region, along with the availability of supportive policies by the regulatory bodies that promote the market players to opt for the development of advanced vascular closure devices to reduce the pain of patients and eliminate the associated risks, are also anticipated to contribute to the market’s growth in the region. In addition, the region's expanding healthcare industry and rising commercialization of medical products are also anticipated to boost market growth during the forecast period.

Europe Market Insights

Furthermore, it is anticipated that the transradial closure device market in Europe will rank second, with a proportion of about 35% by the end of 2035. The market is benefiting from developments in key end-use sectors like hospitals, specialty clinics, independent catheterization centers, and others.  According to the WHO, cardiovascular disease is responsible for more than half of all deaths in Europe, and 80 percent of premature heart disease and stroke can be avoided. Additionally, as more people become aware of ways to improve cardiovascular health, there is a huge increase in demand for transradial closure devices.

APAC Market Insights

Additionally, it is anticipated that by the end of 2035, the South Asia area will hold a satisfactory share of the market share among all other regions.  With consistent development in recent years, South Asia has emerged as a viable market for transradial devices. According to the World Health Organization, South Asia's healthcare sector is gradually expanding. Over the course of the forecast period, the South Asian transradial closure devices market is anticipated to grow owing to the growing use of these devices in surgical and diagnostic operations.

Transradial-Closure-Devices-Market-regional

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of transradial closure devices is evaluated at USD 347.71 million.

The global transradial closure devices market size exceeded USD 320.06 million in 2025 and is set to expand at a CAGR of over 9.6%, surpassing USD 800.46 million revenue by 2035.

By 2035, North America is projected to command the largest 37% share of the transradial closure devices market, owing to the high prevalence of heart disease, a growing elderly population, and access to advanced healthcare facilities.

Key players in the market include Medtronic plc, Teleflex Incorporated, Merit Medical Systems, Inc., Abbott Laboratories, Fisher & Paykel Healthcare Corporation Limited, Beijing Demax Medical Technology Co., Ltd., Semler Technologies, Inc., Endocor GmbH, Morris Innovative, Inc., Transluminal Technologies, LLC.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos